Solid Biosciences (SLDB) Short-term Investments: 2017-2024
Historic Short-term Investments for Solid Biosciences (SLDB) over the last 6 years, with Sep 2024 value amounting to $106.7 million.
- Solid Biosciences' Short-term Investments rose 13.72% to $106.7 million in Q3 2024 from the same period last year, while for Sep 2024 it was $106.7 million, marking a year-over-year increase of 13.72%. This contributed to the annual value of $49.6 million for FY2023, which is 14.94% down from last year.
- According to the latest figures from Q3 2024, Solid Biosciences' Short-term Investments is $106.7 million, which was up 13.04% from $94.4 million recorded in Q2 2024.
- In the past 5 years, Solid Biosciences' Short-term Investments ranged from a high of $108.6 million in Q2 2022 and a low of $90,000 during Q2 2021.
- In the last 3 years, Solid Biosciences' Short-term Investments had a median value of $88.5 million in 2024 and averaged $75.7 million.
- In the last 5 years, Solid Biosciences' Short-term Investments crashed by 99.02% in 2020 and then surged by 120,535.56% in 2022.
- Quarterly analysis of 5 years shows Solid Biosciences' Short-term Investments stood at $400,000 in 2020, then reached $88.6 million in 2021, then crashed by 34.19% to $58.3 million in 2022, then declined by 14.94% to $49.6 million in 2023, then increased by 13.72% to $106.7 million in 2024.
- Its Short-term Investments stands at $106.7 million for Q3 2024, versus $94.4 million for Q2 2024 and $88.5 million for Q1 2024.